EN
返回档案库

档案库 · 医疗与健康 · 产品决策 · 2018–2026

Neko Health:预防性体检做成生意

这家瑞典初创公司提供299英镑的全身扫描服务;2026年融资7亿美元,估值18亿美元。

Neko Health

它在赌什么消费者会自掏腰包做预防性体检。自研硬件、软件、诊所;用10-15分钟的扫描推动年度复购。在扩

做的是什么生意

Operates its own clinics in Stockholm, London and other locations, offering a 10–15-minute full-body scan with 70+ sensors and millions of data points plus a doctor consultation, charging per visit and encouraging annual repeat purchases.

启动资金After 2018, Daniel Ek invested about €30M upfront through Prima Materia; in July 2023, a $65M Series A (led by Lakestar, with Atomico, General Catalyst, and Prima Materia); in January 2025, a $260M Series B (led by Lightspeed, valued at $1.8B); in July 2026, a $700M Series C (led by Lightspeed and O.G. Venture Partners).

起因

In 2018, Daniel Ek saw Hjalmar Nilsonne's post about the healthcare market on Twitter and contacted him by direct message; neither had a healthcare background (Nilsonne had previously worked in climate tech), and their conversation produced the idea of preventive healthcare plus vertical integration. The team spent six years developing its own scanning hardware and software and building its own clinics, opening the first store in Stockholm in February 2023; appointment slots sold out within hours of opening.

经过

In July 2023, completed a $65M Series A (led by Lakestar, with Atomico, General Catalyst, and Prima Materia participating); in 2024, opened the second store in London, by which time Stockholm had completed about 3,000 scans and Sweden's waitlist had about 20,000 people. In January 2025, completed a $260M Series B, led by Lightspeed, valued at $1.8B, with cumulative scans of 10,000 and a global waitlist of more than 100,000 people, and 80% of members prepaid for the next year's scan on the spot.

结果

In July 2026, raised another $700M Series C (led by Lightspeed and O.G. Venture Partners), with cumulative financing exceeding $1B; already operating in the United Kingdom and Sweden, preparing for its first U.S. clinic in New York; as of July 2026, cumulative scans exceeded 100,000 people and waitlist and appointments exceeded 350,000 people. The company is still expanding rapidly.

背景

Neko Health是一家瑞典预防性医疗公司,由Spotify创始人丹尼尔·埃克和连续创业者亚尔马·尼尔松创立。它不向医院卖设备,而是自研全身扫描硬件和软件,自营诊所:一次约10-15分钟的扫描收集数百万个健康数据点,涵盖皮肤痣、代谢综合征、心脑血管风险、血糖等指标,随后由医生面诊解读结果,定价约299英镑。

两人2018年在Twitter认识后,开始了这场长达六年的坚持——埃克通过他的投资公司Prima Materia先期投入约3000万欧元,团队直到2023年2月才在斯德哥尔摩开出第一家店,开业当天预约名额几小时内售罄。2023年7月,公司完成6500万美元A轮(Lakestar领投,Atomico和General Catalyst跟投)。

2024年,Neko扩张到伦敦;斯德哥尔摩累计约3000次扫描,等待名单约2万人。2025年1月,完成2.6亿美元B轮,光速领投,估值18亿美元;那时全球等待名单超过10万人,累计扫描1万次,80%的会员在检查结束时直接预付下一年。

2026年7月,公司又融资7亿美元(光速和O.G. Venture Partners领投),累计融资超过10亿美元,准备在纽约开第一家美国诊所;截至当时,累计扫描超过10万人次,等待名单和预约超过35万人。它的赌注是健康人愿意为早期发现付费——需求端验证目前成立,剩下的是让诊所网络和诊断能力可复制。

这件事要成立,得有什么

  • 需求已验证:开业当天名额售罄;80%预付下一年。
  • 垂直整合形成数据和经验的护城河。
  • 投资人看到平台潜力:从6500万美元A轮到18亿美元估值。
  • 风险:扫描不等于改善结果;自费限制了可及性。

可借鉴之处

把预防变成产品:垂直整合硬件、软件和诊所。用复购率(80%预付)证明价值,吸引资本。但临床证据和监管信任是根本。

后续进展

截至2026年9月1日,Neko Health在斯德哥尔摩和伦敦运营,准备进入纽约。已完成10万多次扫描,等待名单35万以上。在7亿美元C轮后,扩张诊所和研发。竞争对手如Zoi、Aware、Midjourney出现。接下来:证明长期的临床和商业价值。

资料来源

发现哪里写错了?告诉我们。

轮到你了

你刚读完一家。说说你在做什么,看看谁在赌同一件事。

免费账号 · 3 次免费提问 · 不用绑卡

相关案例